SG11201707166TA - Anti-inflammatory polypeptides - Google Patents
Anti-inflammatory polypeptidesInfo
- Publication number
- SG11201707166TA SG11201707166TA SG11201707166TA SG11201707166TA SG11201707166TA SG 11201707166T A SG11201707166T A SG 11201707166TA SG 11201707166T A SG11201707166T A SG 11201707166TA SG 11201707166T A SG11201707166T A SG 11201707166TA SG 11201707166T A SG11201707166T A SG 11201707166TA
- Authority
- SG
- Singapore
- Prior art keywords
- inflammatory polypeptides
- polypeptides
- inflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/524—CH2 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/72—Increased effector function due to an Fc-modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/638,905 US9845358B2 (en) | 2011-12-19 | 2015-03-04 | Anti-inflammatory polypeptides |
| PCT/US2016/020813 WO2016141262A1 (en) | 2015-03-04 | 2016-03-04 | Anti-inflammatory polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201707166TA true SG11201707166TA (en) | 2017-09-28 |
Family
ID=56848864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201707166TA SG11201707166TA (en) | 2015-03-04 | 2016-03-04 | Anti-inflammatory polypeptides |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10844125B2 (he) |
| EP (1) | EP3265124A4 (he) |
| JP (1) | JP2018508522A (he) |
| KR (1) | KR20230028600A (he) |
| CN (1) | CN107847586A (he) |
| AU (1) | AU2016226115B2 (he) |
| CA (1) | CA2978580A1 (he) |
| EA (2) | EA038554B1 (he) |
| IL (1) | IL254284B2 (he) |
| SG (1) | SG11201707166TA (he) |
| WO (1) | WO2016141262A1 (he) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8470318B2 (en) * | 2005-11-07 | 2013-06-25 | The Rockefeller University | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| WO2018159787A1 (ja) * | 2017-03-01 | 2018-09-07 | 国立大学法人北海道大学 | 疾患モデル非ヒト動物の製造方法、疾患モデル非ヒト動物、該動物を用いた薬剤のスクリーニング方法及び疾患リスク判定方法 |
| CN112924671A (zh) * | 2021-01-28 | 2021-06-08 | 中国医学科学院北京协和医院 | 一种用于诊断类风湿关节炎合并肺间质纤维化的生物标志物及其用途 |
| WO2024071010A1 (ja) * | 2022-09-26 | 2024-04-04 | 国立大学法人京都大学 | Ｔ細胞の製造方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7064191B2 (en) | 2000-10-06 | 2006-06-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for purifying antibody |
| US20040002587A1 (en) | 2002-02-20 | 2004-01-01 | Watkins Jeffry D. | Fc region variants |
| US8188231B2 (en) | 2002-09-27 | 2012-05-29 | Xencor, Inc. | Optimized FC variants |
| CA2595169A1 (en) | 2005-01-12 | 2006-07-20 | Xencor, Inc. | Antibodies and fc fusion proteins with altered immunogenicity |
| RU2007145509A (ru) | 2005-05-09 | 2009-06-20 | Гликарт Биотехнологи Аг (Ch) | Антигенсвязывающие молекулы, имеющие модифицированные fc-участки и измененное связывание с fc-рецепторами |
| CA2614046C (en) | 2005-06-30 | 2018-05-15 | Centocor, Inc. | Methods of controlling properties of therapeutic proteins, fc-containing therapeutic proteins of the g2s2 alpha-(2,3)-sialylated glycoform, and uses thereof |
| EP2455100A3 (en) | 2005-11-07 | 2012-11-07 | The Rockefeller University | Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
| US8470318B2 (en) * | 2005-11-07 | 2013-06-25 | The Rockefeller University | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| EA022780B1 (ru) | 2006-04-05 | 2016-03-31 | Дзе Рокфеллер Юниверсити | СПОСОБ ПОВЫШЕНИЯ ПРОТИВОВОСПАЛИТЕЛЬНОЙ АКТИВНОСТИ И СНИЖЕНИЯ ЦИТОТОКСИЧЕСКОЙ АКТИВНОСТИ ПРЕПАРАТА IgG |
| NZ597651A (en) | 2006-10-26 | 2012-07-27 | Univ Rockefeller | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| US8465741B2 (en) | 2006-12-20 | 2013-06-18 | Mmrglobal, Inc. | Antibodies and methods for making and using them |
| US8540992B2 (en) | 2006-12-28 | 2013-09-24 | Michael Naso | Methods and vectors for generating asialylated immunoglobulins |
| US20110020269A1 (en) * | 2007-05-08 | 2011-01-27 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for modifying t cell immune responses and inflammation |
| KR101380732B1 (ko) | 2007-05-30 | 2014-04-10 | 포항공과대학교 산학협력단 | 면역글로불린 융합 단백질 |
| US20100286067A1 (en) | 2008-01-08 | 2010-11-11 | Biogenerix Ag | Glycoconjugation of polypeptides using oligosaccharyltransferases |
| MX2010011598A (es) | 2008-04-22 | 2010-12-15 | Univ Rockefeller | Metodos para identificar compuestos anti-inflamatorios. |
| BR112012010252A2 (pt) | 2009-10-29 | 2016-12-06 | Janssen Biotech Inc | variantes de glicosilação de anticorpo |
| PT2647707T (pt) | 2010-11-30 | 2018-11-15 | Chugai Pharmaceutical Co Ltd | Agente terapêutico indutor de toxicidade |
| CA2832106A1 (en) | 2011-04-07 | 2012-10-11 | Neotope Biosciences Limited | Compositions and methods for treating diseases of protein aggregation involving ic3b deposition |
| IN2014CN04765A (he) * | 2011-12-19 | 2015-09-18 | Univ Rockefeller |
-
2016
- 2016-03-04 US US15/555,194 patent/US10844125B2/en active Active
- 2016-03-04 EA EA201791937A patent/EA038554B1/ru unknown
- 2016-03-04 KR KR1020177028445A patent/KR20230028600A/ko unknown
- 2016-03-04 CA CA2978580A patent/CA2978580A1/en active Pending
- 2016-03-04 AU AU2016226115A patent/AU2016226115B2/en active Active
- 2016-03-04 WO PCT/US2016/020813 patent/WO2016141262A1/en active Application Filing
- 2016-03-04 EP EP16759551.1A patent/EP3265124A4/en not_active Withdrawn
- 2016-03-04 CN CN201680025702.2A patent/CN107847586A/zh active Pending
- 2016-03-04 EA EA202191471A patent/EA202191471A1/ru unknown
- 2016-03-04 JP JP2017546144A patent/JP2018508522A/ja active Pending
- 2016-03-04 SG SG11201707166TA patent/SG11201707166TA/en unknown
-
2017
- 2017-09-03 IL IL254284A patent/IL254284B2/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018508522A (ja) | 2018-03-29 |
| KR20230028600A (ko) | 2023-02-28 |
| EP3265124A1 (en) | 2018-01-10 |
| US10844125B2 (en) | 2020-11-24 |
| CN107847586A (zh) | 2018-03-27 |
| EA201791937A1 (ru) | 2018-07-31 |
| EA038554B1 (ru) | 2021-09-14 |
| IL254284B1 (he) | 2023-03-01 |
| IL254284B2 (he) | 2023-07-01 |
| EP3265124A4 (en) | 2018-09-12 |
| AU2016226115A1 (en) | 2017-10-19 |
| CA2978580A1 (en) | 2016-09-09 |
| EA202191471A1 (ru) | 2022-01-31 |
| IL254284A0 (he) | 2017-10-31 |
| US20180051087A1 (en) | 2018-02-22 |
| AU2016226115B2 (en) | 2021-03-25 |
| WO2016141262A1 (en) | 2016-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201802261B (en) | Polypeptides | |
| IL262482A (he) | פוליפפטידים חדשים | |
| IL255767A (he) | פוליפפטידים חדשים | |
| ZA201702537B (en) | Peptides having anti-inflammatory properties | |
| HK1250041A1 (zh) | 多肽 | |
| GB201611530D0 (en) | Novel polypeptides | |
| ZA201704366B (en) | Il-17a-binding polypeptides | |
| HK1250040A1 (zh) | 多肽 | |
| ZA201701348B (en) | New polypeptides | |
| IL254284A0 (he) | פוליפפטידים אנטי-דלקתיים | |
| GB201520536D0 (en) | Peptides | |
| GB201619652D0 (en) | Novel polypeptides | |
| GB201520546D0 (en) | Peptides | |
| GB201520545D0 (en) | Peptides | |
| GB201520544D0 (en) | Peptides | |
| GB201520539D0 (en) | Peptides | |
| GB201520550D0 (en) | Peptides | |
| GB201520543D0 (en) | Peptides | |
| GB201520541D0 (en) | Peptides | |
| GB201520548D0 (en) | Peptides | |
| GB201520542D0 (en) | Peptides | |
| GB201515245D0 (en) | Novel polypeptides | |
| GB201520537D0 (en) | Peptides | |
| GB201520538D0 (en) | Peptides | |
| GB201520535D0 (en) | Peptides |